Stay updated on Nivolumab for High-Risk HCC Post-Hepatic Tx Clinical Trial

Sign up to get notified when there's something new on the Nivolumab for High-Risk HCC Post-Hepatic Tx Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab for High-Risk HCC Post-Hepatic Tx Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    Added two Tainan locations (Tainan, Taiwan, 736 and Tainan, TNN, Taiwan, 704) and removed two Tainan City entries (Tainan City, Taiwan, 736; Tainan City, Taiwan, 704).
    Difference
    0.0%
    Check dated 2025-11-12T00:01:42.000Z thumbnail image
  2. Check
    10 days ago
    No Change Detected
  3. Check
    17 days ago
    Change Detected
    Summary
    The page changes appear limited to cosmetic layout updates and do not modify core study content. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2025-10-28T05:09:56.000Z thumbnail image
  4. Check
    39 days ago
    Change Detected
    Summary
    Release v3.2.0 is introduced with a government-funding notice and updated operating status information; prior v3.1.0 is removed.
    Difference
    3%
    Check dated 2025-10-06T16:03:37.000Z thumbnail image
  5. Check
    46 days ago
    Change Detected
    Summary
    Updated page to v3.1.0; removed several drug-safety topic categories (Drug Safety, Counterfeit Drugs, Pharmaceutical Preparations, Substandard Drugs) and retained the older version tag v3.0.2, suggesting a reorganization of content around a new version.
    Difference
    0.3%
    Check dated 2025-09-29T09:54:57.000Z thumbnail image
  6. Check
    60 days ago
    Change Detected
    Summary
    Revision updated from v3.0.1 to v3.0.2; 'Back to Top' was removed.
    Difference
    0.2%
    Check dated 2025-09-15T00:20:32.000Z thumbnail image
  7. Check
    67 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content or other important elements.
    Difference
    0.2%
    Check dated 2025-09-07T20:44:48.000Z thumbnail image

Stay in the know with updates to Nivolumab for High-Risk HCC Post-Hepatic Tx Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab for High-Risk HCC Post-Hepatic Tx Clinical Trial page.